United States Drug Enforcement Administration

DEA Europe is focused on combating the drug trafficking and money laundering activities of Transnational Criminal Organizations (TCOs) operating in Europe, with an emphasis on investigations that directly impact the United States.  TCOs are the driving force behind the many drug threats facing Europe, including the trafficking of multi-ton quantities of cocaine, heroin, methamphetamine, and cannabis, the production and distribution of synthetic drugs, the diversion of precursor chemicals, and the laundering of illicit drug proceeds.   

Comprised of 16 offices covering 51 countries, DEA Europe works in close coordination with its European law enforcement partners and DEA offices worldwide to achieve its mission of dismantling TCOs impacting the United States and Europe.  In addition to conducting bilateral investigations, DEA Europe engages with its host-nation partners to provide training on a variety of issues related to drug law enforcement.  These international partnerships are critical to combating the increasingly complex and sophisticated organizations that threaten the security of the United States and Europe.   

In addition to its 16 country offices, DEA Europe maintains liaisons at the European Union Agency for Law Enforcement Cooperation (Europol) headquartered in The Hague, Netherlands, and at the Maritime Analysis and Operations Centre-Narcotics (MAOC-N) in Lisbon, Portugal.  DEA’s presence at these multi-national law enforcement centers, as well as coordination with the United Nations Office on Drugs and Crime (UNODC), allows for timely information sharing with international partners on operational and strategic initiatives related to drug law enforcement. 

For more information about a particular country, visit the CIA World Factbook.